Nasus Pharma Ltd. NSRX
2.87 USD +0.05 (+1.77%)
Regular-session close
3.00 +0.13 +4.53%
Pre-market · Nov 16, 7:07 AM ET
2.81 Day range 2.94
1.98 52-week range 9.50
- YTD
- -68.63%
- 1 year
- -63.67%
News
globenewswire.com Nasus Pharma Announces Abstracts Accepted for Presentation at ACAAI 2026 TEL AVIV, Israel, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative…
benzinga.com This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday Analysts initiated coverage with Buy/Overweight ratings on KZIA ($27), PSQL ($12), NSRX ($7) and LGCY ($16).benzinga.com Maxim Group Initiates Coverage On Nasus Pharma with Buy Rating, Announces Price Target of $7 Maxim Group analyst Naz Rahman initiates coverage on Nasus Pharma (AMEX:NSRX) with a Buy rating and announces Price Target of $7.
